PHARMACEUTICAL PREPARATIONS PROPHYLAXIS

Brand Owner (click to sort) Address Description
AXXIMA Axxima Pharmaceuticals AG Am Klopferspitz 19 D-82152 Planegg-Martinsried Pharmaceutical preparations for prophylaxis and treatment of infectious diseases and their pathological effects;
BAYHEP B BAYER AKTIENGESELLSCHAFT Kaiser-Wilhelm-Allee 1 Leverkusen 51373 Germany pharmaceutical preparations for the prophylaxis of acute exposure to blood containing HBSAG, perinatal exposure of infants born to HBSAG-positive mothers, sexual exposure to an hbsag-positive person and household exposure to persons with acute HBV infection;B;
GONITRO G. POHL-BOSKAMP GMBH & CO. KG Kieler Strasse 11 Hohenlockstedt 25551 Germany Pharmaceutical preparations for the prophylaxis and the treatment of coronary heart diseases;
GONITRO STICKPACK G. POHL-BOSKAMP GMBH & CO. KG Kieler Strasse 11 Hohenlockstedt 25551 Germany Pharmaceutical preparations for the prophylaxis and the treatment of coronary heart diseases;GO NITRO STICKPACK;
MILDROGEL GRINDEKS, Akciju sabiedriba Krustpils iela 53 LV-1057 Riga Latvia Pharmaceutical preparations for the prophylaxis and treatment of cardiological, cardiovascular, antiischemic and neurological diseases, medicine for the prophylaxis and treatment of cardiological, cardiovascular, antiischemic and neurological diseases, tissue lesions and associated skin irritation disease in the form of ointments and gels; pharmaceutical preparations for wound treatment, namely, ointments and gels for the treatment of wounds;
MILDRONATE GRINDEKS, Akciju sabiedriba Krustpils iela 53 LV-1057 Riga Latvia Pharmaceutical preparations for the prophylaxis and treatment of cardiological, cardiovascular, antiischemic and neurological diseases;
MYCEPT Panacea Biotec Ltd. B-1 Extension, A-27 Mohan Cooperative Industrial Estate Mathura Rd, New Delhi 110044 India Pharmaceutical preparations for prophylaxis of organ rejection in patients receiving allogenic liver or hepatic or cardiac transplant;
MYNITRO G. POHL-BOSKAMP GMBH & CO. KG Kieler Strasse 11 Hohenlockstedt 25551 Germany Pharmaceutical preparations for the prophylaxis and the treatment of coronary heart diseases;MY NITRO;
MYNITRO STICKPACK G. POHL-BOSKAMP GMBH & CO. KG Kieler Strasse 11 Hohenlockstedt 25551 Germany Pharmaceutical preparations for the prophylaxis and the treatment of coronary heart diseases;MY NITRO STICK PACK;
NEOMILDRONATE GRINDEKS, Akciju sabiedriba Krustpils iela 53 LV-1057 Riga Latvia Pharmaceutical preparations for the prophylaxis and treatment of cardiological, cardiovascular, antiischemic and neurological diseases;
NITROBOLT G. POHL-BOSKAMP GMBH & CO. KG Kieler Strasse 11 Hohenlockstedt 25551 Germany Pharmaceutical preparations for the prophylaxis and the treatment of coronary heart diseases;NITRO BOLT;
NITROBOLT STICKPACK G. POHL-BOSKAMP GMBH & CO. KG Kieler Strasse 11 Hohenlockstedt 25551 Germany Pharmaceutical preparations for the prophylaxis and the treatment of coronary heart diseases;NITRO BOLT STICK PACK;
PANGRAF Panacea Biotec Ltd. B-1 Extension, A-27 Mohan Cooperative Industrial Estate Mathura Rd, New Delhi 110044 India Pharmaceutical preparations for prophylaxis of organ rejection and for treatment of autoimmune disease conditions;
SANERGY GRINDEKS, Akciju sabiedriba Krustpils iela 53 LV-1057 Riga Latvia Pharmaceutical preparations for the prophylaxis and treatment of cardiological, cardiovascular, antiischemic and neurological diseases, medicine for the prophylaxis and treatment of cardiological, cardiovascular, antiischemic and neurological diseases, vitamins, dietetic substances adapted for medical use, food supplements adapted for medical use;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.